Champions Oncology, Inc. (CSBR) Dividend History

Champions Oncology, Inc. (CSBR) is a provider of personalized cancer immunotherapy solutions. The company develops and offers patient-derived tumor models to help guide treatment decisions and accelerate drug development. Through its platform, Champions Oncology enables more effective and targeted cancer therapies by allowing researchers and clinicians to evaluate the efficacy of various treatments on individual patient samples.

855 N. Wolfe Street, Baltimore, MD, 21205
Phone: 410-369-0365
Website: https://www.championsoncology.com

Dividend History

Champions Oncology, Inc. currently does not pay dividends

Company News

  • Insiders Buying Solid Biosciences And 2 Other Stocks

    Although U.S. stocks closed mixed on Friday, there were a few notable insider trades. When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision. Below is a look at a few recent notable insider purchases. For more, check out Benzinga's insider transactions platform. Solid Biosciences The Trade: Solid Biosciences Inc. (NASDAQ: SLDB) Director Joseph Edelman acquired a ...

    Benzinga
    Featured Companies: AXR SLDB
  • Champions Oncology, Inc. (CSBR) Reports Q3 Loss, Tops Revenue Estimates

    Champions Oncology, Inc. (CSBR) delivered earnings and revenue surprises of -200% and 2.26%, respectively, for the quarter ended January 2023. Do the numbers hold clues to what lies ahead for the stock?

    Zacks Investment Research
    Featured Companies: GANX
Page data last updated 08/19/2025 13:55:44 UTC